9/16/2021  9:59:59 PM Chg. +0.30 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
108.09USD +0.28% 255,489
Turnover: 27.5 mill.
-Bid Size: - -Ask Size: - 191 bill.USD 4.48% 39.59

Business description

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
 

Management board & Supervisory board

CEO
Richard A. Gonzalez
Management board
Robert A. Michael, Henry O. Gosebruch, Carrie Strom, Dr. Azita Saleki-Gerhardt, Jeffrey R. Stewart, Laura J. Schumacher, Michael E. Severino, Rae L. Livingston, Timothy J. Richmond
Supervisory board
Richard A. Gonzalez, Brett J. Hart, Edward J. Rapp, Edward M. Liddy, Frederick H. Waddell, Glenn F. Tilton, Melody B. Meyer, Rebecca B. Roberts, Robert J. Alpern, M.D., Roxanne S. Austin, Thomas Freyman, William H.L. Burnside
 

Company data

Name: AbbVie Inc.
Address: 1 North Waukegan Road,North Chicago, Illinois 60064-6400, USA
Phone: +1-847-932-7900
Fax: -
E-mail: -
Internet: www.abbvie.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 84.92%
IPO date: -

Investor relations

Name: Liz Shea
IR phone: +1-847-935-2211
IR Fax: -
IR e-mail: liz.shea@abbvie.com

Company calendar

CW 47 | 11/15/2021 Dividend Payment
 

Main Shareholders

Freefloat
 
84.92%
The Vanguard Group, Inc.
 
8.08%
BlackRock, Inc.
 
7.00%